With the ever-increasing focus on informed
decision-making by all healthcare stakeholders, there is a need to establish evidence far beyond the basic product information of yesteryears.
The foundation of a successful market access and pricing strategy is identification, demonstration and presentation of the therapeutic and economic value of a product.
Globally pharmaceutical, medical device, and biotechnology innovators require effective market access strategies to get them optimal reimbursement for their healthcare interventions while maintaining affordability for payers so that patients have access to effective therapies with minimal delay. In simple terms, successful market access, pricing and reimbursement strategies ensure the delivery of the right treatment to the right patient at the right time, and at the right price.
Health economics and outcomes research (HEOR) output is an important component of the evidence package to support any Market Access strategy. The two are intrinsically related and complementary to one another. Successful companies develop a HEOR roadmap with market access strategy considerations taken into account through the early stages of clinical development, rather than as an afterthought to only be developed close to regulatory approval.
Actu-Real offers solutions and services to help payers, providers and pharmaceutical companies optimize objectives of access, quality and cost of healthcare, with the backbone of a fit-for-purpose, all-in-one technology platform for data integration, advanced analytics, reporting and visualization.